Cold virus turned cancer hunter: first patients receive experimental treatment

NCT ID NCT06977737

Recruiting now Disease control Sponsor: Accession Therapeutics Limited Source: ClinicalTrials.gov ↗

Summary

This early-stage trial is testing ATTR-01, an experimental treatment made from a modified common cold virus. The virus is designed to specifically infect cancer cells and deliver an immune-boosting drug to help the body's own defenses attack the tumor. The study will first find a safe dose in adults with certain advanced solid tumors who have run out of standard treatment options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

, St James' University Hospital
RECRUITING

Leeds, United Kingdom
Beatson West of Scotland Cancer Centre
RECRUITING

Glasgow, Scotland, United Kingdom
Churchill Hospital
RECRUITING

Oxford, United Kingdom
START Barcelona
RECRUITING

Barcelona, Spain
Start Fjd
RECRUITING

Madrid, Spain
Start Hm Ciocc
RECRUITING

Madrid, Spain
Velindre Cancer Centre
RECRUITING

Cardiff, Wales, United Kingdom

Conditions

Explore the condition pages connected to this study.

SOLID TUMOR, ADULT